Please login to the form below

Not currently logged in
Email:
Password:

Teva's vice chair steps down

Amir Elstein to take over from Moshe Many
Teva Amir Elstein

Teva faces yet more senior changes as Prof Moshe Many announced his intention to step down as vice chairman at the beginning of next year.

According to Teva, Prof Many is leaving his position for “personal reasons” and will be replaced by board director Amir Elstein. This change will take place on January 1, 2014.

It is second major change at the top for Teva in recent months after the company announced its president and CEO Jeremy Levin was stepping down after just 18 months in the position.

Commenting on Prof Many's decision to step down, Teva's chairman Dr Phillip Frost said: "I would like to thank Prof Many for his outstanding service as vice chairman and wish Amir success in continuing Moshe's good work."

16th December 2013

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Mainimage2
The role of digital health technology tools in supporting medical adherence
How DHT-based digital interventions can help to support patients and improve adherence...
How To Tell A Better Silent Story
They say a picture's worth 1,000 words, which is incredibly helpful when telling a silent story....
Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...